Literature DB >> 14621408

Pattern of medical charges after quitting smoking among those with and without arthritis, allergies, or back pain.

Shirley Musich1, Stephanie D Faruzzi, Chifung Lu, Timothy McDonald, David Hirschland, Dee W Edington.   

Abstract

PURPOSE: To examine the time frame of changes in medical charges after smoking cessation among (1) those with arthritis, allergies, or back pain and (2) those with none of these chronic conditions.
DESIGN: Cross-sectional study using smoking status determined in 1996 and 4-year average medical charges measured from 1996 to 1999.
SETTING: Nationwide manufacturing corporation (General Motors Corporation).
SUBJECTS: A total of 20,332 employees and spouses who completed a health risk appraisal in 1996 were younger than 64 years, were enrolled in indemnity or preferred provider organization health insurance plans during 1996 to 1999, and self-reported no preexisting primary diseases. MEASURES: Participants were categorized according to 1996 self-reported smoking status into six subgroups: current smokers, former smokers by years since cessation (0-4, 5-9, 10-14, and > or = 15 years), and never smokers. Average annual medical charges (1996-1999) among those with chronic conditions (arthritis, allergies, or back pain; N = 11,921) or without chronic conditions (N = 8411) were examined independently. Never smokers in each group were compared to respective smoker and former smoker subgroups.
RESULTS: Current smokers and former smokers without chronic conditions who quit fewer than 5 years earlier had higher medical charges compared with never smokers ($2613 and $3356 vs. $2203, respectively). Among those with chronic conditions, current smokers, former smokers who quit 0 to 4 years ago, and former smokers who quit 5 to 9 years ago had higher medical charges than never smokers ($4208, $4027, and $4050 vs. $3108, respectively).
CONCLUSIONS: It took approximately 5 years for former smokers without chronic conditions and nearly 10 years for former smokers with chronic conditions to reduce their medical charges to levels close to their respective never smokers. Health promotion practitioners and other decision makers should consider the impact of chronic conditions on the course of medical savings when implementing smoking cessation programs at the worksite.

Entities:  

Mesh:

Year:  2003        PMID: 14621408     DOI: 10.4278/0890-1171-18.2.133

Source DB:  PubMed          Journal:  Am J Health Promot        ISSN: 0890-1171


  11 in total

1.  Implementing point of care "e-referrals" in 137 clinics to increase access to a quit smoking internet system: the Quit-Primo and National Dental PBRN HI-QUIT Studies.

Authors:  Rajani S Sadasivam; Timothy P Hogan; Julie E Volkman; Bridget M Smith; Heather L Coley; Jessica H Williams; Kathryn Delaughter; Midge N Ray; Gregg H Gilbert; Daniel E Ford; Jeroan J Allison; Thomas K Houston
Journal:  Transl Behav Med       Date:  2013-12       Impact factor: 3.046

2.  Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.

Authors:  Paul G Barnett; Abra Jeffers; Mark W Smith; Bruce K Chow; Miles McFall; Andrew J Saxon
Journal:  Nicotine Tob Res       Date:  2015-05-04       Impact factor: 4.244

3.  The Cost-Effectiveness of Nicotine Replacement Therapy Sampling in Primary Care: a Markov Cohort Simulation Model.

Authors:  Brian Chen; Gerard A Silvestri; Jennifer Dahne; Kyueun Lee; Matthew J Carpenter
Journal:  J Gen Intern Med       Date:  2022-01-28       Impact factor: 6.473

Review 4.  A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

Authors: 
Journal:  Am J Prev Med       Date:  2008-08       Impact factor: 5.043

5.  Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized, controlled trial.

Authors:  Paul G Barnett; Wynnie Wong; Abra Jeffers; Sharon M Hall; Judith J Prochaska
Journal:  J Clin Psychiatry       Date:  2015-10       Impact factor: 4.384

6.  A longitudinal study of medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in hospitalizations for cardiovascular disease.

Authors:  Thomas Land; Nancy A Rigotti; Douglas E Levy; Mark Paskowsky; Donna Warner; Jo-Ann Kwass; Leann Wetherell; Lois Keithly
Journal:  PLoS Med       Date:  2010-12-07       Impact factor: 11.069

7.  Effects of Tobacco Smoking on the Degeneration of the Intervertebral Disc: A Finite Element Study.

Authors:  Shady Elmasry; Shihab Asfour; Juan Pablo de Rivero Vaccari; Francesco Travascio
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

8.  A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions.

Authors:  Andrea C Villanti; Yiding Jiang; David B Abrams; Bruce S Pyenson
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

9.  Three cases of previous smokers with rheumatoid arthritis who did not respond to tumor necrosis factor inhibitors were treated successfully with an anti-interleukin-6 receptor antibody.

Authors:  Yasuo Iwata
Journal:  Case Rep Rheumatol       Date:  2015-01-14

Review 10.  Medical costs and quality-adjusted life years associated with smoking: a systematic review.

Authors:  Shari P Feirman; Allison M Glasser; Lyubov Teplitskaya; David R Holtgrave; David B Abrams; Raymond S Niaura; Andrea C Villanti
Journal:  BMC Public Health       Date:  2016-07-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.